Trading Symbol: CRA
CUSIP Number: 69332S201
TERMS OF THE SETTLEMENT: The Settlement consists of $11,000,000 in cash and will include interest on the Settlement Fund prior to distribution.
CLASS DESCRIPTION: On behalf of all persons who purchased PE Corporation Celera Genomics Group common stock issued in or traceable to a Secondary Public Offering conducted by PE Corporation on February 29, 2000, inclusive.
IMPORTANT DATES:
DATE TO SEEK EXCLUSION
FROM THE CLASS: JUNE 8, 2010
DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: AUGUST 16, 2010
TO OBTAIN A PROOF OF CLAIM FORM:
Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com
Keine Kommentare:
Kommentar veröffentlichen